Existing vaccines may be less effective against the Covid-19 Omicron variant, the CEO’s of Moderna and Pfizer admitted on Monday. Speaking to the Financial Times, the CEO of Moderna warned that it would take months before pharmaceutical companies could manufacture new variant-specific jabs at scale. He added that the high number of Omicron mutations on […] Read the full story on GreekReporter.com.
 |
| READ THE ORIGINAL POST AT greekreporter.com |
